Your browser doesn't support javascript.
loading
Expanding the phenotypic spectrum of TRAPPC11-related muscular dystrophy: 25 Roma individuals carrying a founder variant.
Justel, Maria; Jou, Cristina; Sariego-Jamardo, Andrea; Juliá-Palacios, Natalia Alexandra; Ortez, Carlos; Poch, Maria Luisa; Hedrera-Fernandez, Antonio; Gomez-Martin, Hilario; Codina, Anna; Dominguez-Carral, Jana; Muxart, Jordi; Hernández-Laín, Aurelio; Vila-Bedmar, Sara; Zulaica, Miren; Cancho-Candela, Ramon; Castro, Margarita Del Carmen; de la Osa-Langreo, Alberto; Peña-Valenceja, Alfonso; Marcos-Vadillo, Elena; Prieto-Matos, Pablo; Pascual-Pascual, Samuel Ignacio; López de Munain, Adolfo; Camacho, Ana; Estevez-Arias, Berta; Musokhranova, Uliana; Olivella, Mireia; Oyarzábal, Alfonso; Jimenez-Mallebrera, Cecilia; Domínguez-González, Cristina; Nascimento, Andrés; García-Cazorla, Àngels; Natera-de Benito, Daniel.
Affiliation
  • Justel M; Neuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Jou C; Department of Paediatrics, Complejo asistencial de Salamanca, Salamanca, Spain.
  • Sariego-Jamardo A; Applied Research in Neuromuscular Diseases, Sant Joan de Deu Research Institute, Barcelona, Spain.
  • Juliá-Palacios NA; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
  • Ortez C; Department of Pathology, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Poch ML; Paediatric Neurology Unit, Hospital Universitario Marques de Valdecilla, Santander, Spain.
  • Hedrera-Fernandez A; Neurometabolic Unit and Synaptic Metabolism Lab, Departments of Neurology, IPR (Institut Pediàtric de Recerca), CIBERER and MetabERN, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Gomez-Martin H; Neuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Codina A; Applied Research in Neuromuscular Diseases, Sant Joan de Deu Research Institute, Barcelona, Spain.
  • Dominguez-Carral J; Department of Paediatrics, Hospital San Pedro, Logrono, Spain.
  • Muxart J; Paediatric Neurology Unit, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Hernández-Laín A; Department of Paediatrics, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.
  • Vila-Bedmar S; Applied Research in Neuromuscular Diseases, Sant Joan de Deu Research Institute, Barcelona, Spain.
  • Zulaica M; Unit of Epilepsy, Sleep and Neurophysiology, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Cancho-Candela R; Department of Radiology, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Castro MDC; Neuropathology Unit, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • de la Osa-Langreo A; Neuromuscular Unit, Department of Neurology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Peña-Valenceja A; Biodonostia, Neurosciences Area, Neuromuscular Diseases Laboratory, Hospital Universitario de Donostia, San Sebastian, Spain.
  • Marcos-Vadillo E; Paediatric Neurology Unit, Hospital Universitario Rio Hortega de Valladolid, Valladolid, Spain.
  • Prieto-Matos P; Department of Paediatrics, Hospital Clinico Universitario de Valladolid, Valladolid, Spain.
  • Pascual-Pascual SI; Department of Paediatrics, Hospital Universitario Doctor Peset, Valencia, Spain.
  • López de Munain A; Department of Paediatrics, Hospital Rio Carrion, Palencia, Spain.
  • Camacho A; Department of Clinical Biochemistry, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.
  • Estevez-Arias B; Department of Paediatrics, Complejo asistencial de Salamanca, Salamanca, Spain.
  • Musokhranova U; La Paz University Hospital, Madrid, Spain.
  • Olivella M; Biodonostia, Neurosciences Area, Neuromuscular Diseases Laboratory, Hospital Universitario de Donostia, San Sebastian, Spain.
  • Oyarzábal A; Paediatric Neurology Unit, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Jimenez-Mallebrera C; Neuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Domínguez-González C; Laboratory of Neurogenetics and Molecular Medicine-IPER, Sant Joan de Deu Research Institute, Barcelona, Spain.
  • Nascimento A; Neurometabolic Unit and Synaptic Metabolism Lab, Departments of Neurology, IPR (Institut Pediàtric de Recerca), CIBERER and MetabERN, Hospital Sant Joan de Déu, Barcelona, Spain.
  • García-Cazorla À; Biosciences Department, Faculty of Sciences, Technology and Engineering, Universitat de Vic-Universitat Central de Catalunya, Vic, Spain.
  • Natera-de Benito D; Neurometabolic Unit and Synaptic Metabolism Lab, Departments of Neurology, IPR (Institut Pediàtric de Recerca), CIBERER and MetabERN, Hospital Sant Joan de Déu, Barcelona, Spain.
J Med Genet ; 60(10): 965-973, 2023 10.
Article in En | MEDLINE | ID: mdl-37197784
ABSTRACT

BACKGROUND:

Limb-girdle muscular dystrophies (LGMD) are a heterogeneous group of genetically determined muscle disorders. TRAPPC11-related LGMD is an autosomal-recessive condition characterised by muscle weakness and intellectual disability.

METHODS:

A clinical and histopathological characterisation of 25 Roma individuals with LGMD R18 caused by the homozygous TRAPPC11 c.1287+5G>A variant is reported. Functional effects of the variant on mitochondrial function were investigated.

RESULTS:

The c.1287+5G>A variant leads to a phenotype characterised by early onset muscle weakness, movement disorder, intellectual disability and elevated serum creatine kinase, which is similar to other series. As novel clinical findings, we found that microcephaly is almost universal and that infections in the first years of life seem to act as triggers for a psychomotor regression and onset of seizures in several individuals with TRAPPC11 variants, who showed pseudometabolic crises triggered by infections. Our functional studies expanded the role of TRAPPC11 deficiency in mitochondrial function, as a decreased mitochondrial ATP production capacity and alterations in the mitochondrial network architecture were detected.

CONCLUSION:

We provide a comprehensive phenotypic characterisation of the pathogenic variant TRAPPC11 c.1287+5G>A, which is founder in the Roma population. Our observations indicate that some typical features of golgipathies, such as microcephaly and clinical decompensation associated with infections, are prevalent in individuals with LGMD R18.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Roma / Muscular Dystrophies, Limb-Girdle / Intellectual Disability / Microcephaly / Muscular Dystrophies Limits: Humans Language: En Journal: J Med Genet Year: 2023 Type: Article Affiliation country: Spain

Full text: 1 Database: MEDLINE Main subject: Roma / Muscular Dystrophies, Limb-Girdle / Intellectual Disability / Microcephaly / Muscular Dystrophies Limits: Humans Language: En Journal: J Med Genet Year: 2023 Type: Article Affiliation country: Spain